Altimmune (NASDAQ:ALT) is set to give its latest quarterly earnings report on Tuesday, 2025-08-12. Here's what investors need to know before the announcement.
Analysts estimate that Altimmune will report an earnings per share (EPS) of $-0.32.
Anticipation surrounds Altimmune's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Earnings Track Record
During the last quarter, the company reported an EPS beat by $0.09, leading to a 1.04% drop in the share price on the subsequent day.
Here's a look at Altimmune's past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.35 | -0.34 | -0.35 | -0.34 |
| EPS Actual | -0.26 | -0.33 | -0.32 | -0.35 |
| Price Change % | -1.0% | 4.0% | 0.0% | -3.0% |
Performance of Altimmune Shares
Shares of Altimmune were trading at $3.45 as of August 08. Over the last 52-week period, shares are down 46.75%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
To track all earnings releases for Altimmune visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
